text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 129618-40-2 | Product Number: N0922

Nevirapine


Purity: >98.0%(GC)
Synonyms:
  • 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
Product Documents:
200MG
$109.00
15   ≥60  Contact Us
1G
$346.00
11   23   Contact Us

* Please contact our distributors or TCI to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.


Supplemental Product Information:

This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.

Product Number N0922
Purity / Analysis Method >98.0%(GC)
Molecular Formula / Molecular Weight C__1__5H__1__4N__4O = 266.30 
Physical State (20 deg.C) Solid
Storage Temperature Frozen (<0°C)
Condition to Avoid Heat Sensitive
Packaging and Container 1G-Glass Bottle with Plastic Insert (View image),  200MG-Glass Bottle with Plastic Insert (View image)
CAS RN 129618-40-2
Reaxys Registry Number 4757598
PubChem Substance ID 160871291
Merck Index (14) 6490
MDL Number

MFCD00866928

Specifications
Appearance White to Light yellow powder to crystal
Purity(GC) min. 98.0 %
Purity(Nonaqueous Titration) min. 97.0 %
Melting point 244.0 to 248.0 °C
Properties (reference)
Melting Point 246 °C
Solubility in water Insoluble
Degree of solubility in water < 0.1 g/l  
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H302 : Harmful if swallowed.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
Related Laws:
RTECS# JM5562500
Transport Information:
H.S.code* 2933.99-000
*This code is applied to the products when TCI exports from Japan and not for import in your country.
Application
Nevirapine: A Non-Nucleoside Reverse Transcriptase Inhibitor

Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that active against HIV-1. Nevirapine selectively inhibits HIV-1 but not HIV-2 and any of the human DNA polymerases. Nucleoside reverse transcriptases (NRTIs) compete with natural nucleic acid triphosphates for inhibitory action, whereas nevirapine does not compete with the triphosphates. Nevirapine bind to an active site of the reverse transcriptase molecule of HIV-1, and inhibits the transcriptase activity. Therefore, nevirapine is also active against NRTI (e.g. azidothymidine) resistant HIV-1. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.